Trending
Revolutionary Shows Promise 4
Revolutionary Shows Promise 3
Revolutionary Shows Promise 1
Revolutionary aids Treatment Shows Promise
Revolutionary Cancer Treatment Shows Promise
FDA Expands Approval of Vonvendi for von Willebrand Disease, Including Pediatric Use
Child Depression Fluctuations may trigger Parent Depression not vice versa: JAMA
Indoor Air Quality and Diet Found to Regulate Inflammation in Childhood: Study Finds
How Smoking Fuels Pancreatic Cancer Growth and Worsens Outcomes: Study Finds Out
Follow Us:
November 04, 2025

Get In Touch

AstraZeneca Saphnelo subcutaneous self-administration recommended for approval in EU by CHMP for systemic lupus erythematosus Pharma News

AstraZeneca Saphnelo subcutaneous self-administration recommended for approval in EU by CHMP for systemic lupus erythematosus

  • 20 October 2025
  • 2 weeks ago

AstraZeneca to harmonise its listing structure across LSE, STO and NYSE Pharma News

AstraZeneca to harmonise its listing structure across LSE, STO and NYSE

  • 30 September 2025
  • 1 month ago

AstraZeneca Koselugo recommended for approval in EU for plexiform neurofibromas in adults with neurofibromatosis type 1 Pharma News

AstraZeneca Koselugo recommended for approval in EU for plexiform neurofibromas in adults with neurofibromatosis type 1

  • 28 September 2025
  • 1 month ago

AstraZeneca-Daiichi Sankyo get USFDA grants priority review for Enhertu combo for 1st line HER2+ Breast cancer treatment Obstetrics and Gynaecology

AstraZeneca-Daiichi Sankyo get USFDA grants priority review for Enhertu combo for 1st line HER2+ Breast cancer treatment

  • 24 September 2025
  • 1 month ago

AstraZeneca-Amgen Tezspire recommended for approval in EU for chronic rhinosinusitis with nasal polyps Pharma News

AstraZeneca-Amgen Tezspire recommended for approval in EU for chronic rhinosinusitis with nasal polyps

  • 22 September 2025
  • 1 month ago

AstraZeneca announces Rs 176 crore investments in India to expand Chennai GITC Pharma News

AstraZeneca announces Rs 176 crore investments in India to expand Chennai GITC

  • 09 September 2025
  • 1 month ago

USFDA Grants Priority Review To AstraZeneca-Daiichi Sankyo Enhertu For HER2-Low, HER2 Ultralow Breast Cancer Obstetrics and Gynaecology

USFDA Grants Priority Review To AstraZeneca-Daiichi Sankyo Enhertu For HER2-Low, HER2 Ultralow Breast Cancer

  • 19 July 2025
  • 3 months ago

Recent News

Nanotechnology Reverses Alzheimer's Symptoms in Mi...

  • 03 November, 2025

Gum disease could silently cause serious brain dam...

  • 03 November, 2025

Can Early-Day Fasting Significantly Boost Metaboli...

  • 03 November, 2025

Delhi HC bars doctor from running medical centre d...

  • 03 November, 2025

Daily Newsletter

Get all the top stories from Blogs to keep track.